3-decyloxy-propan-1-ol | 60851-88-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-decyloxy-propan-1-ol
• 英文别名: 3-Hydroxypropyl decyl ether；3-Decyloxy-propanol；1-Propanol, 3-(decyloxy)-；3-decoxypropan-1-ol
• CAS: 60851-88-9
• 化学式: C₁₃H₂₈O₂
• 分子量: 216.364
• InChiKey: CFBISZHYSTVKKB-UHFFFAOYSA-N

物化性质

• 沸点：
  80 °C(Press: 1 Torr)
• 密度：
  0.875±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  15
• 可旋转键数：
  12
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-decyloxy-propan-1-ol 在 sulfur 、 三甲胺 作用下， 以 二硫化碳 、 氯仿 为溶剂， 反应 13.0h， 生成
  参考文献：
  名称：

  Brønsted型LFER在磷脂酶C机制研究中的应用†

  摘要：

  磷脂酰肌醇特异性磷脂酶裂解磷脂酰肌醇的磷酸二酯键，形成肌醇 1,2-环磷酸酯和甘油二酯。该酶还接受各种烷基和芳基肌醇磷酸酯作为底物，使其成为通过探测线性自由能关系 (LFER) 研究磷酰基转移机制的合适模型酶。在这项工作中，我们对 Brønsted 型关系 (log k = beta(lg) pK(a) + C) 进行了研究，以比较酶促和非酶促反应的机制，确认早先提出的机制，并进一步评估疏水性的作用在离去基团中作为一般的酸促进因子。观察到两种非酶促 (beta(lg) = -0.65 到 -0) 的高负 Brønsted 系数。73) 和芳基和非疏水性烷基肌醇磷酸酯的酶促裂解 (beta(lg) = -0.58) 表明这些反应仅涉及弱的一般酸催化。相比之下，疏水性烷基肌醇磷酸酯的酶促裂解表现出较低的负布朗斯台德系数（β（lg）= -0.12），表明离去基团上有少量负电荷和有效的一般酸催化。

  DOI：

  10.1021/ja029362s
• 作为产物：
  描述：

  3-decoxypropoxymethylbenzene 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 生成 3-decyloxy-propan-1-ol
  参考文献：
  名称：

  Synthesis and antiproliferative activity of alkylphosphocholines

  摘要：

  Alkylphosphocholines (APC) with one or more methylene groups in the alkyl chain replaced by oxygen atoms or carbonyl groups, or both have been assembled modularly using w-diols as central building blocks. Out of 25 new compounds of this kind, I I were evaluated for their antiproliferative activity on four cell lines and compared with miltefosine to evaluate their hemolytic activity (HA); and cytotoxicity on non-tumoral cells (MT2), used as markers of adverse effects. Compound 13 was more active on cancer cell lines than on non-tumoral cells and the data were similar for MTT and thymidine incorporation assays. It had less HA than miltefosine, Compound 13 could therefore be a candidate for the preparation of compounds with higher cytotoxicity on cancer cells and lower general toxicity. (C) 2003 Elsevier Ireland Ltd. All rights reserved.

  DOI：

  10.1016/j.chemphyslip.2003.08.002

文献信息

• Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
  申请人：Goddard John G.

  公开号：US06949528B1

  公开（公告）日：2005-09-27

  The invention provides anti-apoptotic compositions lysophosphatidic acids and methods for making and using the compositions. Such compositions can also contain LPA potentiating agents, including proteins, lipid membrane structures and polymers such as polyethylene glycols. The compositions can additionally contain other pharmaceutically effective agents such as drugs, antibiotics, wound healing agents and antioxidants.

  该发明提供了抗凋亡组合物溶磷脂酸及其制备和使用方法。这种组合物还可以包含增强LPA作用的剂，包括蛋白质、脂质膜结构和聚合物，如聚乙二醇。该组合物还可以额外含有其他药用有效剂，如药物、抗生素、伤口愈合剂和抗氧化剂。
• [EN] COMPOSITIONS CONTAINING LYSOPHOSPHOTIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF<br/>[FR] COMPOSITIONS CONTENANT DES ACIDES LYSOPHOSPHOTIDIQUES INHIBANT L'APOPTOSE, ET LEURS UTILISATIONS
  申请人：LXR BIOTECHNOLOGY INC.

  公开号：WO1998041213A1

  公开（公告）日：1998-09-24

  (EN) The present invention provides therapeutic compositions containing lysophosphatidic acids, methods for making the compositions, and methods of use thereof.(FR) La présente invention concerne des compositions thérapeutiques contenant des acides lysophosphotidiques, des procédés permettant de fabriquer les compositions, et des procédés d'utilisation de celles-ci.

  该发明提供了含有溶血磷脂酸的治疗组合物、制备该组合物的方法以及使用该组合物的方法。
• Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
  申请人：Bathurst C. Ian

  公开号：US20060063738A1

  公开（公告）日：2006-03-23

  The present invention provides therapeutic compositions containing lysophosphatidic acids, methods for making the compositions, and methods of use thereof.

  本发明提供了含有溶血磷脂酸的治疗组合物，制备该组合物的方法以及使用该组合物的方法。
• COMPOSITIONS CONTAINING LYSOPHOSPHATIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF
  申请人：Goddard G. John

  公开号：US20080076736A1

  公开（公告）日：2008-03-27

  The invention provides anti-apoptotic compositions containing lysophosphatidic acids and methods for making and using the compositions. Such compositions may also contain LPA potentiating agents, including proteins, lipid membrane structures and polymers such as polyethylene glycols. The compositions can additionally contain other pharmaceutically effective agents such as drugs, antibiotics, wound healing agents and antioxidants.

  本发明提供了含有溶血磷脂酸的抗凋亡组合物及其制备和使用方法。这样的组合物还可以含有LPA增效剂，包括蛋白质、脂质膜结构和聚合物，如聚乙二醇。该组合物还可以另外含有其他药效物质，如药物、抗生素、伤口愈合剂和抗氧化剂。
• LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT
  申请人：JNC Corporation

  公开号：EP3275973A1

  公开（公告）日：2018-01-31

  Subject The subject is to provide a liquid crystal composition that includes a polymerizable compound (or polymer) and a polar compound, where the homeotropic alignment of liquid crystal molecules can be achieved by the action of these compounds, and a liquid crystal display device including this composition. This composition satisfies at least one of characteristics such as a high maximum temperature, a low minimum temperature, a small viscosity, a suitable optical anisotropy, a large positive dielectric anisotropy, a large specific resistance, a high stability to ultraviolet light or heat or a large elastic constant, or is suitably balanced regarding at least two of the characteristics. The means concerns a nematic liquid crystal composition that has positive dielectric anisotropy and that includes a polymerizable compound as an first additive and a polar compound as a second additive, and the composition may include a specific liquid crystal compound having a large positive dielectric anisotropy and a specific liquid crystal compound having a high maximum temperature or a small viscosity, and concerns a liquid crystal display device including the composition.

  主题 本课题旨在提供一种液晶组合物，其中包括一种可聚合化合物（或聚合物）和一种极性化合物，通过这些化合物的作用可实现液晶分子的各向同性排列，并提供一种包括这种组合物的液晶显示装置。这种组合物至少满足以下一种特性，如最高温度高、最低温度低、粘度小、光学各向异性合适、正介电各向异性大、比电阻大、对紫外线或热的稳定性高或弹性常数大，或至少在其中两种特性方面适当平衡。 该手段涉及一种具有正介电常数的向列液晶组合物，该组合物包括作为第一添加剂的可聚合化合物和作为第二添加剂的极性化合物，该组合物可包括具有较大正介电常数的特定液晶化合物和具有较高最高温度或较小粘度的特定液晶化合物，还涉及一种包括该组合物的液晶显示设备。